10/17/22 16:42 | 10/13/22 | AXLA | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund IV General Partner LLC | MA | T | | P | 17,029 | 1.64 | 0 | 10,384 | 55 | 29,252 | I | | | | | | | | | | | | | | |
10/17/22 11:12 | 10/13/22 | AXLA | FdBev | Food | Food & Kindred Products | Societe Des Produits Nestle S.A. | V8 | T | | P | 6,000 | 1.64 | 0 | 3,659 | 49 | 11,105 | I | | | | | | | | | | | | | | |
3/18/22 08:31 | 3/16/22 | AXLA | Health | BioPrd | Biological Products, (No Diag | Hinshaw William | MA | DO | P,CEO | P | 25 | 1.91 | 0 | 13 | 37 | 48 | D | | | | | | | | | | | | | | |
3/18/22 08:31 | 3/16/22 | AXLA | Health | BioPrd | Biological Products, (No Diag | Fehlner Paul | MA | O | SVP,GC | P | 20 | 1.91 | 0 | 10 | 101 | 21 | D | | | | | | | | | | | | | | |
3/18/22 08:30 | 3/16/22 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P | 50 | 1.91 | 0 | 26 | 19 | 161 | D | | | | | | | | | | | | | | |
3/18/22 08:30 | 3/16/22 | AXLA | Health | BioPrd | Biological Products, (No Diag | Crane Robert | MA | O | CFO | P | 75 | 1.91 | 0 | 39 | New | 39 | D | | | | | | | | | | | | | | |
3/18/22 08:30 | 3/16/22 | AXLA | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund IV General Partner LLC | MA | T | | P | 12,070 | 1.91 | 0 | 6,319 | 50 | 18,868 | I | | | | | | | | | | | | | | |
3/16/22 11:53 | 3/16/22 | AXLA | FdBev | Food | Food & Kindred Products | Societe Des Produits Nestle S.A. | V8 | T | | P | 6,000 | 1.91 | 0 | 3,141 | 73 | 7,447 | I | | | | | | | | | | | | | | |
5/21/20 17:02 | 5/18/20 | AXLA | FdBev | Food | Food & Kindred Products | Nestle Health Science Us Holdings, Inc. | VA | T | | P | 9,200 | 4.75 | 0 | 1,937 | 82 | 4,306 | I | | | | | | | | | | | | | | |
5/20/20 17:15 | 5/18/20 | AXLA | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund IV General Partner LLC | MA | T | | P | 18,050 | 4.75 | 0 | 3,800 | 132 | 6,683 | I | | | | | | | | | | | | | | |
5/20/20 16:07 | 5/18/20 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P | 238 | 4.75 | 0 | 50 | 73 | 118 | D | | | | | | | | | | | | | | |
3/2/20 19:04 | 2/27/20 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P.m | 54 | 3.66 | 0 | 15 | 28 | 68 | D | | | | | | | | | | | | | | |
1/31/20 20:44 | 1/31/20 | AXLA | Health | BioPrd | Biological Products, (No Diag | Chardonnet Laurent | MA | O | CFO | P | 15 | 4.94 | 0 | 3 | 451 | 4 | D | | | | | | | | | | | | | | |
1/28/20 18:39 | 1/24/20 | AXLA | Health | BioPrd | Biological Products, (No Diag | Chardonnet Laurent | MA | O | CFO | P.m | 3 | 4.93 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
1/21/20 16:38 | 1/17/20 | AXLA | Health | BioPrd | Biological Products, (No Diag | Sohn Catherine A. | MA | D | | P | 5 | 4.87 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
12/3/19 11:20 | 11/26/19 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P.m | 54 | 3.57 | 0 | 15 | 39 | 53 | D | | | | | | | | | | | | | | |
12/2/19 19:31 | 11/26/19 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P.m | 54 | 3.57 | 0 | 15 | 39 | 53 | D | | | | | | | | | | | | | | |
8/5/19 16:55 | 8/1/19 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P.m | 49 | 7.00 | 0 | 7 | 22 | 38 | D | | | | | | | | | | | | | | |
7/18/19 21:54 | 7/17/19 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P | 8 | 7.55 | 0 | 1 | 3 | 31 | D | | | | | | | | | | | | | | |
7/10/19 21:56 | 7/8/19 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P.m | 48 | 8.24 | 0 | 6 | 24 | 30 | D | | | | | | | | | | | | | | |
7/3/19 19:53 | 7/1/19 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P.m | 40 | 8.76 | 0 | 5 | 31 | 19 | D | | | | | | | | | | | | | | |
7/1/19 08:38 | 6/27/19 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P.m | 55 | 10.02 | 0 | 6 | 38 | 20 | D | | | | | | | | | | | | | | |
6/27/19 16:03 | 6/26/19 | AXLA | Health | BioPrd | Biological Products, (No Diag | Epstein David R | MA | D | | P | 139 | 9.57 | 0 | 15 | New | 15 | D | | | | | | | | | | | | | | |
5/15/19 16:18 | 5/13/19 | AXLA | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund IV General Partner LLC | MA | T | | P.d | 10,000 | 20.00 | 0 | 500 | 16 | 3,700 | I | | | | | | | | | | | | | | |